Good evening, and welcome to the Humacyte Virtual Investor Event. [Operator Instructions] As a reminder, this call is being recorded, and a replay will be made available on the Humacyte website ...

HELSINKI, June 16, 2026 (GLOBE NEWSWIRE) -- Aplagon, a clinical-stage biotechnology company developing APAC, a first-in-class antiplatelet and anticoagulant therapy for treating thrombo-inflammatory ...

Abstract: Reliability evaluation of a microprocessor design may reveal vulnerable silicon areas that require protection against faults, but also hardware structures that are inherently more resilient ...

If you bought a Pixel 9 Pro or a Samsung Galaxy Z Fold 7 in the last year, here is some news you will not love: the biggest Android AI feature Google announced in 2026 is not coming to your phone.

DURHAM, N.C., April 27, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at ...

Introduction Arteriovenous fistulae (AVF) are the ‘gold standard’ vascular access for haemodialysis. Universal usage is limited, however, by a high early failure rate. Several small, single-centre ...

aDepartment of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA bResearch Laboratory for Electronics, Massachusetts Institute of Technology ...

More than 4 million people worldwide have end-stage kidney disease that requires hemodialysis, a treatment in which a machine filters waste from the blood. Hemodialysis is a precursor to kidney ...

More than 4 million people worldwide have end-stage kidney disease that requires hemodialysis, a treatment in which a machine filters waste from the blood. Hemodialysis is a precursor to kidney ...

Appendicovesical fistula (AVF) is a rare condition that occurs in children characterized by an abnormal communication between the appendix and the bladder, caused by diseases such as inflammation or ...